Cargando…

Discriminating agonist and antagonist ligands of the nuclear receptors using 3D-pharmacophores

Nuclear receptors (NRs) constitute an important class of therapeutic targets. We evaluated the performance of 3D structure-based and ligand-based pharmacophore models in predicting the pharmacological profile of NRs ligands using the NRLiSt BDB database. We could generate selective pharmacophores fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Lagarde, Nathalie, Delahaye, Solenne, Zagury, Jean-François, Montes, Matthieu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011875/
https://www.ncbi.nlm.nih.gov/pubmed/27602059
http://dx.doi.org/10.1186/s13321-016-0154-2
_version_ 1782451911407960064
author Lagarde, Nathalie
Delahaye, Solenne
Zagury, Jean-François
Montes, Matthieu
author_facet Lagarde, Nathalie
Delahaye, Solenne
Zagury, Jean-François
Montes, Matthieu
author_sort Lagarde, Nathalie
collection PubMed
description Nuclear receptors (NRs) constitute an important class of therapeutic targets. We evaluated the performance of 3D structure-based and ligand-based pharmacophore models in predicting the pharmacological profile of NRs ligands using the NRLiSt BDB database. We could generate selective pharmacophores for agonist and antagonist ligands and we found that the best performances were obtained by combining the structure-based and the ligand-based approaches. The combination of pharmacophores that were generated allowed to cover most of the chemical space of the NRLiSt BDB datasets. By screening the whole NRLiSt BDB on our 3D pharmacophores, we demonstrated their selectivity towards their dedicated NRs ligands. The 3D pharmacophores herein presented can thus be used as a predictor of the pharmacological activity of NRs ligands. [Figure: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13321-016-0154-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5011875
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-50118752016-09-07 Discriminating agonist and antagonist ligands of the nuclear receptors using 3D-pharmacophores Lagarde, Nathalie Delahaye, Solenne Zagury, Jean-François Montes, Matthieu J Cheminform Research Article Nuclear receptors (NRs) constitute an important class of therapeutic targets. We evaluated the performance of 3D structure-based and ligand-based pharmacophore models in predicting the pharmacological profile of NRs ligands using the NRLiSt BDB database. We could generate selective pharmacophores for agonist and antagonist ligands and we found that the best performances were obtained by combining the structure-based and the ligand-based approaches. The combination of pharmacophores that were generated allowed to cover most of the chemical space of the NRLiSt BDB datasets. By screening the whole NRLiSt BDB on our 3D pharmacophores, we demonstrated their selectivity towards their dedicated NRs ligands. The 3D pharmacophores herein presented can thus be used as a predictor of the pharmacological activity of NRs ligands. [Figure: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13321-016-0154-2) contains supplementary material, which is available to authorized users. Springer International Publishing 2016-09-06 /pmc/articles/PMC5011875/ /pubmed/27602059 http://dx.doi.org/10.1186/s13321-016-0154-2 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Lagarde, Nathalie
Delahaye, Solenne
Zagury, Jean-François
Montes, Matthieu
Discriminating agonist and antagonist ligands of the nuclear receptors using 3D-pharmacophores
title Discriminating agonist and antagonist ligands of the nuclear receptors using 3D-pharmacophores
title_full Discriminating agonist and antagonist ligands of the nuclear receptors using 3D-pharmacophores
title_fullStr Discriminating agonist and antagonist ligands of the nuclear receptors using 3D-pharmacophores
title_full_unstemmed Discriminating agonist and antagonist ligands of the nuclear receptors using 3D-pharmacophores
title_short Discriminating agonist and antagonist ligands of the nuclear receptors using 3D-pharmacophores
title_sort discriminating agonist and antagonist ligands of the nuclear receptors using 3d-pharmacophores
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011875/
https://www.ncbi.nlm.nih.gov/pubmed/27602059
http://dx.doi.org/10.1186/s13321-016-0154-2
work_keys_str_mv AT lagardenathalie discriminatingagonistandantagonistligandsofthenuclearreceptorsusing3dpharmacophores
AT delahayesolenne discriminatingagonistandantagonistligandsofthenuclearreceptorsusing3dpharmacophores
AT zaguryjeanfrancois discriminatingagonistandantagonistligandsofthenuclearreceptorsusing3dpharmacophores
AT montesmatthieu discriminatingagonistandantagonistligandsofthenuclearreceptorsusing3dpharmacophores